Hologic have pumped more into LDX than just the $10M USD up front payments. A heap of the services revenue has come from Hologic for this device and other tests as well.
You would hazzard a guess that the menu of tests developed for Hologic and outside of Hologic will be available on the one device eventually. Prior discussion around Hologic deals with IR:
This fuels the bullish outlook i have for the company and the reasons I keep topping up when I can.
At some point, there will be a tide change and this will re rate, regardless of what the other pundits believe.
A lot of major players sign non exclusive agreements etc to white label product etc for sale and most of the time, these can be ceased with minimal notice and no up front payments. The fact Hologic has already outlaid $10+Million USD to LDX for the manufacturing of the device is no small thing to bark at.
Add to My Watchlist
What is My Watchlist?
